Published in Hepatitis Weekly, September 4th, 2006
Study 1: A recent study from Spain has chronicled the effect of highly active anti-retroviral therapy (HAART) and hepatitis C virus (HCV) co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1 (HIV-1)-infected individuals.
"This study aimed to determine the effect of HAART and HCV co-infection on peripheral levels of interleukin (IL)-2, IL-10, IL-12 (p70), IL-18 and soluble tumor necrosis factor receptor type II (sTNFRII)," wrote C. Tornero and colleagues, San Francisco de Borja Hospital.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.